Dr. Paul Marik’s book ‘Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer’ disappeared from Amazon without any warning. The next day, on 17 September, Amazon emailed Dr. Marik saying that his account had been terminated for spreading misinformation which was damaging to their customers.

“With that, they’ve essentially banned me from ever having another account at Amazon,” Dr. Marik said.

“Obviously this is pure censorship,” he said. 

“I need to emphasise,” he said, “that this [book] is highly referenced … there are over 860 peer-reviewed references.  Almost every statement is referenced by the peer-reviewed literature … This is not misleading information.  This is scientifically valid information from the peer-reviewed medical literature.”

Dr. Marik is a pulmonary and critical care specialist and Chief Scientific Officer of Front Line Covid-19 Critical Care Alliance (“FLCCC Alliance”). He is one of the FLCCC’s founding members and is involved in the development of its protocols.

His book ‘Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer’ provides a comprehensive review of the published literature on repurposed drugs and metabolic interventions for treating cancer.  The book is not intended as a standalone guide for treating cancer, but rather as a well-researched clearinghouse of information that picks up where traditional cancer therapies leave off.

First published in 2023, it is a valuable resource for healthcare professionals, patients and researchers seeking to understand the role of repurposed drugs and metabolic interventions in cancer treatment.

In the book, Dr. Marik emphasises the importance of thinking creatively about readily available interventions, backed by science, to improve patient outcomes.  The book highlights options for repurposed drugs that can be used in cancer treatment.  It also discusses metabolic interventions such as:

• Vitamin D3 and its role in cancer prevention and treatment.
• Melatonin and its potential benefits and side effects.
• Other nutrients and supplements with potential therapeutic benefits.

You can download a copy of Dr. Marik’s book from the FLCCC Alliance website HERE.

FLCCC Alliance have published an open letter to Amazon challenging the banning of Dr. Marik’s book.  We have republished the letter below.

An Open Letter to Amazon on Behalf of Cancer Patients Worldwide

To Jeff Bezos and the Leadership at Amazon,

Representing the voices of cancer patients and their families across the globe, FLCCC Alliance is writing to express our deep disappointment and strong condemnation of Amazon’s recent decision to ban ‘Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer’ by Dr. Paul Marik. This book, backed by over 860 peer-reviewed studies, has been a life-saving resource for thousands of patients seeking integrative treatment options, many of whom have been failed by conventional therapies alone.

Cancer is one of the greatest public health challenges of our time. The American Cancer Society projects an unprecedented rise in cancer diagnoses this year, especially in younger people. Traditional treatments like surgery, chemotherapy and radiation have advanced, but they are not enough. In the wake of the covid pandemic, emerging threats like turbo cancers have pushed oncologists and medical researchers to explore every possible avenue of treatment – including the use of repurposed drugs and metabolic interventions as highlighted in Dr. Marik’s book.

Dr. Marik’s book, which ranked #118 out of over 50,000 Cancer (Books) on Amazon and #35 in Medical Research (Books), has been a resource for nearly 15,000 readers on Amazon and accessed by more than 200,000 people on FLCCC’s website alone. These numbers highlight the urgent need for this information.

The book has provided a clearinghouse of essential information, allowing doctors to think creatively about accessible, affordable therapies that could significantly improve patient outcomes. However, despite the overwhelming support, Amazon unjustly banned this book on 16 September 2024, citing claims of “misleading information” and “defrauding customers.” Amazon has yet to provide Dr. Marik with any examples or explanation. Amazon has gone as far as to cancel Dr. Marik’s publishing account and ban him from publishing any future books on the platform. Again, without citing any specific issues of concern.

It is essential to understand that ‘Cancer Care’ does not replace conventional treatments but complements them. Dr. Marik’s extensive research is designed to support patients and physicians in using scientifically backed, repurposed medications alongside traditional therapies to enhance results and improve quality of life. The decision to censor this book silences a critical conversation on innovative cancer care options and undermines the principles of free speech and medical information access.

This decision is seen by many as an attempt by Big Tech and the pharmaceutical industry to suppress cost-effective, scientifically validated alternatives to expensive conventional treatments like chemotherapy, a $200 billion industry.

While the FLCCC continues to make this book available for free on our website to ensure no one is denied access, the choice to remove it from Amazon – a global marketplace relied upon by millions – limits the reach and impact of this critical information. It is unconscionable to deny cancer patients, who are already fighting for their lives, the knowledge they need to explore every possible treatment option.

As co-founder and Chief Scientific Officer at FLCCC, Dr. Marik’s professional expertise is unquestionable – he has authored over 700 peer-reviewed journal articles, 80 book chapters and four critical care books. He is one of the most published critical care physicians globally, with advanced certifications in Internal Medicine, Critical Care, Neurocritical Care and Nutrition Science.

We demand that Amazon immediately reverse its decision and reinstate Dr. Marik’s book for sale on your platform. This is not just a matter of restoring access to information; it is a matter of life and death for many patients seeking hope in the form of alternative and integrative treatments.

We urge Amazon to do the right thing and allow cancer patients and their families the freedom to access information that could potentially save their lives.

Sincerely,

FLCCC Alliance, 19 September 2024